Revathi Suppiah,MD

MD

Medical Oncologist

Revathi Suppiah Phoenix
quotation

I was drawn to Cancer Treatment Centers of America because of the comprehensive model of care and its incredible mission. I am excited for the future of CTCA.

Location
CTCA Phoenix
14200 West Celebrate Life Way
Goodyear, Arizona 85338
Scottsdale
9755 N. 90th St.
Scottsdale, AZ 85258
Suites A-100 and B-130
Specialties
Medical Oncology
Hematology
Education
Medical school:

Sri Ramachandra Medical College & Research Institute, Chennai, India

Residency:

Internal Medicine – University of Missouri School of Medicine, Columbia

Internal Medicine – Wayne State University/Sinai-Grace Hospital, Detroit, MI

Fellowship:
Hematology/Oncology – Cleveland Clinic, Cleveland, OH
Certifications

Hematology, Oncology and Internal Medicine - American Board of Internal Medicine

Dr. Revathi Suppiah rejoined Cancer Treatment Centers of America® (CTCA) in September 2022 after an 18-month interlude conducting clinical research for a pharmaceutical company. Dr Suppiah, who served as Hematologist-Oncologist at CTCA® Chicago from September 2012 to October 2020, is excited to continue working with her multidisciplinary team to develop comprehensive, personalized care plans for her patients at CTCA Phoenix and the CTCA Outpatient Care Center in Scottsdale, Arizona. She returned to CTCA with extensive experience as a clinical researcher, including serving as principal investigator on multiple clinical trials. She has co-authored several publications in scientific journals and abstracts for national meetings and has written on topics such as metastatic gastrointestinal malignancies and the importance of liquid tumor biopsies. She has a particular interest in lung and gastrointestinal tract

Dr. Suppiah came back to CTCA because she missed clinical medicine and working with patients. And she values the long-term physician-patient relationships.

“I believe medical oncologists have a central role on a cancer patient’s multidisciplinary care team,” says Dr. Suppiah. “We are integral patient educators who can play an important role in helping patients make informed decisions, which requires us to have strong communication with our patients and other providers of the medical care team.” 

After receiving her medical degree from Sri Ramachandra Medical College and Research Institute in Chennai, India, Dr. Suppiah went on to complete internal medicine residencies at the University of Missouri School of Medicine in Columbia, Missouri, and the Wayne State University School of Medicine in Detroit, Michigan. She then completed a hematology and oncology fellowship at Cleveland Clinic in Cleveland, Ohio, eventually becoming triple board certified by the American Board of Internal Medicine in hematology, internal medicine and medical oncology.

Dr. Suppiah has been surrounded by a family of doctors throughout her life. She grew up helping at her father’s clinic, inspired by the impact he made as an internist on their small-town community in Illinois and learning the importance of developing meaningful relationships with patients. She loved science and biology in high school, so medicine seemed like the natural next step in her career. Dr. Suppiah decided to pursue the field of oncology because she enjoys the diversity of skills and expertise required by cancer and hematology. Her goal is to see that her patients receive quality care and experience positive outcomes while maintaining their quality of life. She’s also passionate about giving back to her community and serves on the Medical Advisory Board for BreastCancerHub.org.

In her free time, Dr. Suppiah enjoys spending time with her family and friends, exercising and going for long walks, cooking vegetarian food and reading.

Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.